CLINICAL_TRIALS
trial_result
· 2022-02-21
Clinical Trial Update: Herniorrhaphy Study for Opioid Elimination [Phase 3]
Summary
Phase 3 clinical trial update for a herniorrhaphy study targeting opioid elimination in analgesia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Heron Therapeutics | Conditions: Analgesia | Phase 3 | Status: COMPLETED